ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Changes in serum erythropoietin and the reticulocyte count during chemotherapy for leukemias
Author(s): Sawabe Y, Kikuno K, Iseki T, Iida S, Tabata Y, Yonemitsu H
Source: EUROPEAN JOURNAL OF HAEMATOLOGY    Volume: 57    Issue: 5    Pages: 384-388    Published: NOV 1996  
Times Cited: 8     References: 10     
Abstract: We serially determined serum erythropoietin (Epo) and the reticulocyte count in patients with various types of leukemia during chemotherapy. Serum Epo increased soon after the initiation of chemotherapy and decreased after the termination of therapy irrespective of the types of leukemia or treatment regimen. However, it did not stay at low level but fluctuated. The reticulocyte count, on the other hand, showed a transient rise while serum Epo level descended. The value of serum Epo when increased was higher than the value expected from hemoglobin concentration; this finding was similar to that in aplastic anemia, These results suggest that myelosuppression is a major factor for the increase in serum Epo level during leukemia chemotherapy.
Document Type: Article
Language: English
Reprint Address: Sawabe, Y (reprint author), CHIBA UNIV HOSP, DIV LAB MED, CHUO KU, 1-8-1 INOHANA, CHIBA 260, JAPAN
Addresses:
1. CHIBA UNIV, SCH MED, DEPT LAB MED, CHUO KU, CHIBA 260, JAPAN
2. CHIBA UNIV, SCH MED, DEPT INTERNAL MED 1, CHUO KU, CHIBA 260, JAPAN
Publisher: MUNKSGAARD INT PUBL LTD, 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
Subject Category: Hematology
IDS Number: WB505
ISSN: 0902-4441
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo